Tag: Hormones: Misc.
Gender-Affirming Medication Use Rare in U.S. Transgender Adolescents From 2018 to 2022
Findings seen among privately insured adolescents who identify as transgender and gender-diverse
Recommendations Updated on Diagnosis, Management of Premature/Primary Ovarian Insufficiency
Significant changes from previous guideline include recommendation that only FSH >25 IU required for POI diagnosis
Long-Term Sex Hormone Treatment in Transgender Care Tied to Changes in Body Composition
Longitudinal changes seen in regional fat and muscle composition and cardiometabolic biomarkers
Hormone-Modulating Therapy May Reduce Dementia Risk in Breast Cancer
Greatest reduction seen for women aged 65 to 74 years who self-identify as Black
Racial, Ethnic Differences Seen in Breast Cancer Treatment Declination
American Indian, Alaska Native, other; Asian or Pacific Islander; Black patients more likely to decline surgery
Neoadjuvant Chemohormonal Therapy Aids Locally Advanced Prostate Cancer
Significant benefits in terms of three-year biochemical progression-free survival seen for NCHT versus neoadjuvant hormonal therapy
Evidence Lacking for Gender Dysphoria Treatments for Teens
Two systematic reviews show inadequate evidence for use of treatment to suppress or lessen effect of puberty, hormone treatment
Psychological, Biological Responses to Social Stressors ID’d in Hormonal Contraceptive Users
Increases in glucocorticoids in response to the Trier Social Stress Test were common for women using hormonal contraceptives
Receipt of Novel Hormonal Therapy for Advanced Prostate Cancer Varies With Race
Black patients had significantly lower use of NHT than White patients, which persisted at five years
Oral Contraceptives May Protect Against Rheumatoid Arthritis
In contrast, use of menopausal hormone therapy may increase the risk for late-onset rheumatoid arthritis